Marcaine/epinephrine 0.5% Inj, 30ml

Manufacturer HOSPIRA Active Ingredient Bupivacaine and Epinephrine(byoo PIV a kane & ep i NEF rin) Pronunciation byoo-PIV-uh-kane & ep-i-NEF-rin
WARNING: Seizures, sudden loss of heart function, and death have been reported when this drug was used as an epidural during childbirth. Most of the time, this happened with a certain strength of this drug that is not meant for use during labor. If you have questions, talk with the doctor. @ COMMON USES: It is used to numb an area before a procedure.
đŸˇī¸
Drug Class
Local Anesthetic, Vasoconstrictor
đŸ§Ŧ
Pharmacologic Class
Amide Local Anesthetic; Alpha- and Beta-Adrenergic Agonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Sep 1972
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

This medication is a combination of two drugs: bupivacaine, which is a numbing medicine (local anesthetic), and epinephrine, which is a medicine that narrows blood vessels. It is used to numb a specific part of your body to block pain during surgery, childbirth, or other medical procedures. The epinephrine helps the numbing effect last longer and reduces bleeding at the injection site.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It is essential to follow the instructions carefully. This medication is administered via injection.

Storage and Disposal

This medication will be administered in a hospital or doctor's office, so you will not need to store it at home.

Missed Dose

Since this medication is given as needed in a healthcare setting, you will not need to worry about missing a dose. The healthcare provider will administer the medication according to your individual needs.
💡

Lifestyle & Tips

  • Report any unusual symptoms immediately during or after the procedure.
  • Avoid activities requiring fine motor skills or full sensation until the numbing effect has completely worn off (e.g., driving, operating machinery, handling hot objects).
  • Protect the numb area from injury (e.g., burns, cuts) as you won't feel pain.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly variable based on procedure and site of injection. Common concentrations are 0.25% or 0.5%. For 0.5% solution, typical doses range from 50-175 mg (10-35 mL) for major nerve blocks, 75-150 mg (15-30 mL) for epidural, and up to 200 mg (40 mL) for infiltration. Epinephrine concentration is typically 1:200,000 (5 mcg/mL).

Condition-Specific Dosing:

single_dose_max_bupivacaine: 225 mg (with epinephrine)
24_hour_max_bupivacaine: 400 mg
single_dose_max_epinephrine: 0.2 mg (200 mcg)
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for routine use; extreme caution due to immature hepatic function and higher risk of systemic toxicity. Dosing is highly individualized and often avoided.
Infant: Not established for routine use; extreme caution. Dosing is highly individualized and often avoided.
Child: 0.25% or 0.5% solution. Dosing is weight-based, typically 1-2 mg/kg of bupivacaine (with epinephrine) per single injection. Max dose: 2.5 mg/kg (up to 175 mg) of bupivacaine per single injection, not to exceed 400 mg/24 hours. Epinephrine dose should also be considered (max 5 mcg/kg).
Adolescent: Similar to adult dosing, but consider weight and physiological maturity. Max dose: 2.5 mg/kg (up to 175 mg) of bupivacaine per single injection, not to exceed 400 mg/24 hours.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment generally required for bupivacaine, as renal excretion of unchanged drug is minimal. Epinephrine is rapidly metabolized.
Moderate: No specific dose adjustment generally required, but monitor for signs of toxicity due to potential accumulation of active metabolites (e.g., PPX) or altered protein binding.
Severe: Use with caution. Monitor closely for signs of systemic toxicity. While unchanged bupivacaine excretion is low, metabolites may accumulate. Epinephrine is rapidly metabolized.
Dialysis: Bupivacaine is not significantly removed by hemodialysis. Use with caution and monitor for toxicity.

Hepatic Impairment:

Mild: Use with caution. Consider lower doses and monitor for toxicity due to reduced metabolism.
Moderate: Reduced doses are recommended. Monitor closely for signs of systemic toxicity due to impaired metabolism of bupivacaine.
Severe: Contraindicated or used with extreme caution at significantly reduced doses. Severe hepatic impairment can lead to prolonged half-life and increased risk of systemic toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Bupivacaine is an amide-type local anesthetic that reversibly blocks the initiation and conduction of nerve impulses by decreasing the permeability of the neuronal membrane to sodium ions. This stabilizes the membrane and inhibits depolarization, preventing the propagation of the action potential. Epinephrine is a sympathomimetic amine that acts on alpha- and beta-adrenergic receptors, causing vasoconstriction at the site of injection. This vasoconstriction prolongs the duration of bupivacaine's action by slowing its systemic absorption, reduces systemic toxicity, and decreases local bleeding.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable, depends on site of injection, vascularity, and presence of epinephrine. Systemic absorption is slower and peak plasma levels are lower when combined with epinephrine.
Tmax: 5-30 minutes (depending on site of injection and presence of epinephrine).
FoodEffect: Not applicable (parenteral administration).

Distribution:

Vd: 0.7-2.4 L/kg (Bupivacaine)
ProteinBinding: Approximately 95% (Bupivacaine), primarily to alpha-1-acid glycoprotein.
CnssPenetration: Yes (crosses blood-brain barrier and placenta).

Elimination:

HalfLife: 2.7 hours (Bupivacaine, in adults); 2-3 minutes (Epinephrine)
Clearance: Approximately 0.58 L/min (Bupivacaine)
ExcretionRoute: Renal (Bupivacaine and its metabolites); Renal (Epinephrine metabolites)
Unchanged: Approximately 5% (Bupivacaine); Negligible (Epinephrine)
âąī¸

Pharmacodynamics

OnsetOfAction: 2-10 minutes (Bupivacaine with epinephrine)
PeakEffect: 15-30 minutes
DurationOfAction: 3-7 hours (Bupivacaine with epinephrine, depending on dose and site)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

There have been reports of cardiac arrest and death associated with the use of bupivacaine for intravenous regional anesthesia (Bier block). Bupivacaine 0.75% is contraindicated for obstetrical epidural anesthesia due to the difficulty in resuscitating cardiac arrest in this population.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Help Immediately

Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of acidosis (too much acid in the blood), such as:
+ Confusion
+ Fast breathing
+ Fast heartbeat
+ Irregular heartbeat
+ Severe stomach pain, nausea, or vomiting
+ Excessive sleepiness
+ Shortness of breath
+ Feeling extremely tired or weak
Signs of methemoglobinemia, a rare but potentially deadly condition, such as:
+ Blue or gray discoloration of the lips, nails, or skin
+ Irregular heartbeat
+ Seizures
+ Severe dizziness or fainting
+ Severe headache
+ Excessive sleepiness
+ Feeling extremely tired or weak
+ Shortness of breath
Other serious side effects, such as:
+ Feeling extremely hot or cold
+ Dizziness or fainting
+ Lightheadedness, sleepiness, confusion, or blurred vision
+ Balance problems
+ Restlessness
+ Anxiety
+ Changes in speech
+ Numbness or tingling in the mouth
+ Metallic taste
+ Ringing in the ears
+ Shakiness
+ Twitching
+ Seizures
+ Breathing difficulties, slow breathing, or shallow breathing
+ Abnormal sensations, such as burning, numbness, or tingling
+ Feeling nervous and excitable
+ Headache
+ Severe nausea or vomiting
+ Abnormal heartbeat, chest pain, or pressure
+ Fever or chills
+ Sneezing
+ Excessive sweating
+ Skin reactions, such as burning, color changes, pain, skin breakdown, or swelling at the injection site
* Spinal-related side effects, such as:
+ Urination difficulties
+ Loss of bladder or bowel control
+ Erectile dysfunction
+ Long-lasting burning, numbness, tingling, or paralysis in the lower half of the body
+ Back pain
+ Stiff neck
+ Sensitivity to light

Other Side Effects

Most medications can cause side effects, but many people experience none or only mild symptoms. If you have any side effects that bother you or persist, contact your doctor for advice. This is not an exhaustive list of possible side effects. If you have questions or concerns, discuss them with your doctor.

Reporting Side Effects

You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Dizziness, lightheadedness, or feeling faint
  • Ringing in the ears (tinnitus)
  • Numbness or tingling around the mouth
  • Blurred vision or double vision
  • Tremors or muscle twitching
  • Feeling anxious, restless, or confused
  • Difficulty breathing or shortness of breath
  • Slow or fast heartbeat, palpitations
  • Chest pain
  • Unusual weakness or drowsiness
  • Seizures
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Certain health conditions, including:
+ Bleeding disorders
+ Abnormal heart rhythms
+ Blood infections or infections at the site where the medication will be administered
+ Low blood pressure (hypotension)
If you are taking any of the following medications:
+ Antidepressants like isocarboxazid, phenelzine, or tranylcypromine
+ Medications for Parkinson's disease, such as selegiline or rasagiline
+ Tricyclic antidepressants, including amitriptyline, amoxapine, clomipramine, desipramine, doxepin, imipramine, nortriptyline, protriptyline, or trimipramine
+ Beta blockers, such as nadolol, propranolol, sotalol, or timolol
All your medications, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is not an exhaustive list, and it is crucial to discuss all your medications and health conditions with your doctor to ensure safe use.

Remember to consult your doctor and pharmacist before taking this medication to verify that it is safe to use with your existing medications and health conditions. Do not initiate, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

When taking this medication, it is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are using this drug.

To ensure your safety, avoid driving and engaging in activities that require alertness until the effects of the medication have worn off and you feel fully awake.

If you have a sulfite allergy, consult your doctor, as some products contain sulfites.

There is a risk of developing a severe blood condition called methemoglobinemia with this medication. This risk may be increased in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, heart problems, or lung problems. Additionally, the risk may be higher when taking certain other medications or in infants under 6 months of age. If you have a history of methemoglobinemia, inform your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

Not all products are suitable for children, so consult your doctor before administering this medication to a child.

If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks of this medication with your doctor to make an informed decision.

Mouth (Local Anesthesia)

While your mouth is numb, avoid eating to prevent accidentally biting your tongue.

Spinal (Regional Anesthesia)

This medication may cause temporary loss of sensation and motor function in the lower half of your body. Until feeling and motor function have returned to normal, do not attempt to get out of bed or engage in any activities that require mobility.
🆘

Overdose Information

Overdose Symptoms:

  • Severe dizziness or lightheadedness
  • Confusion, disorientation
  • Slurred speech
  • Severe tremors or muscle twitching progressing to seizures
  • Unconsciousness
  • Respiratory arrest (stopping breathing)
  • Severe low blood pressure (hypotension)
  • Slow heart rate (bradycardia)
  • Irregular heartbeats (arrhythmias)
  • Cardiac arrest

What to Do:

Overdose is a medical emergency. Immediately call 911 or your local emergency number. If you are with someone who has overdosed, call 911. Management typically involves airway management, oxygenation, ventilatory support, IV fluids, vasopressors for hypotension, benzodiazepines for seizures, and lipid emulsion therapy for severe local anesthetic systemic toxicity (LAST). Call 1-800-222-1222 (Poison Control Center) for additional guidance.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Not for intravenous regional anesthesia (Bier block) due to risk of cardiac arrest.
  • 0.75% Bupivacaine is contraindicated for obstetrical epidural anesthesia due to risk of intractable cardiac arrest.
🔴

Major Interactions

  • Other local anesthetics (additive systemic toxicity)
  • Antiarrhythmics (e.g., Class I antiarrhythmics like lidocaine, mexiletine, tocainide - additive cardiac effects)
  • Monoamine Oxidase Inhibitors (MAOIs) (e.g., phenelzine, tranylcypromine - potentiate pressor effects of epinephrine, leading to hypertensive crisis)
  • Tricyclic Antidepressants (TCAs) (e.g., amitriptyline, imipramine - potentiate pressor effects of epinephrine, leading to hypertensive crisis)
  • Non-selective Beta-blockers (e.g., propranolol, nadolol - can lead to severe hypertension followed by bradycardia due to unopposed alpha-adrenergic effects of epinephrine)
  • Ergot-type oxytocic drugs (e.g., ergonovine, methylergonovine - severe persistent hypertension or cerebrovascular accidents when used with vasoconstrictors like epinephrine)
  • Inhalation anesthetics (e.g., halothane, isoflurane - sensitize myocardium to epinephrine, increasing risk of arrhythmias)
🟡

Moderate Interactions

  • Alpha-adrenergic blocking agents (e.g., prazosin, tamsulosin - may reduce vasoconstrictive effect of epinephrine)
  • Phenothiazines and other antipsychotics (e.g., chlorpromazine - may reverse pressor effect of epinephrine)
  • Thyroid hormones (may increase sensitivity to catecholamines like epinephrine)
  • Digitalis glycosides (increased risk of arrhythmias with epinephrine)
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Patient history and physical exam

Rationale: To identify contraindications, risk factors for toxicity (e.g., cardiac, hepatic, renal disease), and assess overall health status.

Timing: Prior to administration

Vital Signs (HR, BP, RR, SpO2)

Rationale: To establish baseline and detect early signs of systemic toxicity or adverse reactions to epinephrine.

Timing: Prior to administration

Allergy history

Rationale: To identify hypersensitivity to amide-type local anesthetics, sulfites (present in some epinephrine formulations), or other components.

Timing: Prior to administration

📊

Routine Monitoring

Vital Signs (HR, BP, RR, SpO2)

Frequency: Every 5-15 minutes during and immediately after injection, then as clinically indicated.

Target: Within patient's normal physiological range, or as per institutional protocol.

Action Threshold: Significant deviations (e.g., hypotension, bradycardia, tachycardia, hypertension, desaturation) warrant immediate investigation and intervention.

Neurological status (e.g., mental status, dizziness, tinnitus, perioral numbness, tremors)

Frequency: Continuously during and after injection.

Target: Normal mentation, absence of CNS excitatory or depressive symptoms.

Action Threshold: Any new or worsening CNS symptoms (e.g., lightheadedness, confusion, seizures) indicate potential systemic toxicity.

ECG monitoring (especially with large doses or high-risk patients)

Frequency: Continuous during and immediately after injection.

Target: Normal sinus rhythm, absence of arrhythmias.

Action Threshold: Arrhythmias (e.g., bradycardia, ventricular ectopy, wide QRS, asystole) indicate severe cardiac toxicity.

đŸ‘ī¸

Symptom Monitoring

  • Lightheadedness
  • Dizziness
  • Tinnitus
  • Perioral numbness
  • Metallic taste
  • Blurred vision
  • Tremors
  • Muscle twitching
  • Seizures
  • Drowsiness
  • Unconsciousness
  • Respiratory depression/arrest
  • Bradycardia
  • Hypotension
  • Hypertension
  • Tachycardia
  • Palpitations
  • Arrhythmias
  • Chest pain
  • Anxiety
  • Restlessness
  • Nausea/vomiting

Special Patient Groups

🤰

Pregnancy

Category C. Use only if the potential benefit justifies the potential risk to the fetus. Bupivacaine crosses the placenta. Epinephrine can affect uterine blood flow and contractility.

Trimester-Specific Risks:

First Trimester: Limited data, but generally avoided unless absolutely necessary due to potential for organogenesis disruption (though unlikely with single dose).
Second Trimester: Generally considered safer than first or third trimester for necessary procedures, but still Category C.
Third Trimester: Can be used for labor and delivery anesthesia, but careful monitoring is crucial. High doses or inadvertent intravascular injection can lead to maternal and fetal toxicity (e.g., fetal bradycardia, acidosis). The 0.75% concentration is contraindicated for obstetrical epidural anesthesia.
🤱

Lactation

Bupivacaine is excreted into breast milk in small amounts (L2 - probably compatible). Epinephrine is rapidly metabolized and unlikely to be present in breast milk in significant amounts (L1 - compatible). Generally considered safe for breastfeeding mothers when used appropriately.

Infant Risk: Low risk of adverse effects in breastfed infants. Monitor for unusual drowsiness or feeding difficulties in the infant.
đŸ‘ļ

Pediatric Use

Use with extreme caution, especially in infants and young children, due to higher risk of systemic toxicity from lower body weight, immature hepatic metabolism, and potential for relative overdose. Dosing must be carefully calculated on a mg/kg basis. Avoid in neonates and infants unless absolutely necessary and with expert supervision.

👴

Geriatric Use

Use with caution. Elderly patients may be more susceptible to systemic toxicity due to decreased hepatic function, reduced renal clearance of metabolites, and altered body composition. Start with lower doses and titrate slowly. Monitor closely for CNS and cardiovascular adverse effects.

Clinical Information

💎

Clinical Pearls

  • Always aspirate prior to injection to avoid inadvertent intravascular administration, which can lead to severe systemic toxicity (LAST).
  • The presence of epinephrine prolongs the duration of action and reduces systemic absorption, but also adds the risk of epinephrine-related side effects (e.g., tachycardia, hypertension, anxiety, myocardial ischemia, especially in patients with cardiovascular disease).
  • Bupivacaine has a higher potential for cardiotoxicity compared to other local anesthetics like lidocaine. Resuscitation from bupivacaine-induced cardiac arrest can be challenging and may require lipid emulsion therapy.
  • Do not use formulations containing epinephrine in areas with end-arterial supply (e.g., fingers, toes, nose, penis, earlobe) due to risk of ischemia and necrosis.
  • Carefully consider the total dose of both bupivacaine and epinephrine, especially in smaller patients or those with comorbidities.
  • Always have resuscitation equipment and medications (e.g., lipid emulsion, vasopressors, benzodiazepines) readily available when administering bupivacaine.
🔄

Alternative Therapies

  • Lidocaine (shorter duration, less cardiotoxic)
  • Ropivacaine (less cardiotoxic than bupivacaine, similar duration)
  • Levobupivacaine (S-enantiomer of bupivacaine, potentially less cardiotoxic)
  • Tetracaine (ester-type, longer duration, topical/spinal use)
  • Chloroprocaine (ester-type, very short duration)
  • General anesthesia
  • Regional nerve blocks without vasoconstrictor (shorter duration)
  • Non-pharmacological pain management techniques
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30mL vial (0.5% with epinephrine) per 30mL vial
Generic Available: Yes
Insurance Coverage: Generally covered by most prescription drug plans under medical benefit (administered in clinic/hospital setting) or pharmacy benefit (for outpatient use). Tier status varies by plan.
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly; do not flush them down the toilet or pour them down the drain unless instructed to do so by a healthcare professional. If you are unsure about the correct disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may have additional patient information leaflets, so it is a good idea to check with your pharmacist for more information. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken to ensure prompt and effective treatment.